Venous thromboembolic disease Review uri icon

Overview

MeSH Major

  • Neoplasms
  • Thromboembolism

abstract

  • Recognizing the increased risk for VTE in cancer patients is the first step in preventing its occurrence and promptly identifying it in these patients. The panel recommends VTE thromboprophylaxis for all hospitalized patients with cancer who have no contraindications to this therapy, and also emphasizes that an increased level of clinical suspicion of VTE should be maintained for cancer patients. After hospital discharge, the panel recommends that patients at high risk for VTE (e.g., patients who have undergone surgery for cancer) continue to receive VTE prophylaxis for up to 4 weeks postoperation. Careful evaluation and follow-up of cancer patients in whom VTE is suspected, and prompt treatment and follow-up for those diagnosed with VTE is recommended after the cancer status of the patient is assessed and the risks and benefits of treatment are considered. ¬©Journal of the National Comprehensive Cancer Network.

publication date

  • September 2008

Research

keywords

  • Review

Identity

Language

  • eng

PubMed ID

  • 18926086

Additional Document Info

start page

  • 716

end page

  • 53

volume

  • 6

number

  • 8